These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prognostic perspectives of PD-L1 combined with tumor-infiltrating lymphocytes, Epstein-Barr virus, and microsatellite instability in gastric carcinomas. Choi E; Chang MS; Byeon SJ; Jin H; Jung KC; Kim H; Lee KL; Kim W; Park JH; Kim KH; Kim JS; Choi IS; Han DS; Ahn HS; Heo SC Diagn Pathol; 2020 Jun; 15(1):69. PubMed ID: 32498695 [TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and prognostic features of Epstein-Barr virus infection, microsatellite instability, and PD-L1 expression in gastric cancer. Pereira MA; Ramos MFKP; Faraj SF; Dias AR; Yagi OK; Zilberstein B; Cecconello I; Alves VAF; de Mello ES; Ribeiro U J Surg Oncol; 2018 Apr; 117(5):829-839. PubMed ID: 29534305 [TBL] [Abstract][Full Text] [Related]
4. Frequent microsatellite instability in papillary and solid-type, poorly differentiated adenocarcinomas of the stomach. Arai T; Sakurai U; Sawabe M; Honma N; Aida J; Ushio Y; Kanazawa N; Kuroiwa K; Takubo K Gastric Cancer; 2013 Oct; 16(4):505-12. PubMed ID: 23274922 [TBL] [Abstract][Full Text] [Related]
5. Clinicopathological features of tumor mutation burden, Epstein-Barr virus infection, microsatellite instability and PD-L1 status in Chinese patients with gastric cancer. Zhang L; Wang Y; Li Z; Lin D; Liu Y; Zhou L; Wang D; Wu A; Li Z Diagn Pathol; 2021 May; 16(1):38. PubMed ID: 33933102 [TBL] [Abstract][Full Text] [Related]
6. Clinicopathological characteristics of Epstein-Barr virus and microsatellite instability subtypes of early gastric neoplasms classified by the Japanese and the World Health Organization criteria. Tanabe H; Mizukami Y; Takei H; Tamamura N; Omura Y; Kobayashi Y; Murakami Y; Kunogi T; Sasaki T; Takahashi K; Ando K; Ueno N; Kashima S; Yuzawa S; Hasegawa K; Sumi Y; Tanino M; Fujiya M; Okumura T J Pathol Clin Res; 2021 Jul; 7(4):397-409. PubMed ID: 33750036 [TBL] [Abstract][Full Text] [Related]
7. Clinicopathological features of PD-L1 protein expression, EBV positivity, and MSI status in patients with advanced gastric and esophagogastric junction adenocarcinoma in Japan. Yoshida T; Ogura G; Tanabe M; Hayashi T; Ohbayashi C; Azuma M; Kunisaki C; Akazawa Y; Ozawa S; Matsumoto S; Suzuki T; Mitoro A; Fukunaga T; Shimizu A; Fujimoto G; Yao T Cancer Biol Ther; 2022 Dec; 23(1):191-200. PubMed ID: 35220884 [TBL] [Abstract][Full Text] [Related]
8. PD-L1 in small bowel adenocarcinoma is associated with etiology and tumor-infiltrating lymphocytes, in addition to microsatellite instability. Giuffrida P; Arpa G; Grillo F; Klersy C; Sampietro G; Ardizzone S; Fociani P; Fiocca R; Latella G; Sessa F; D'Errico A; Malvi D; Mescoli C; Rugge M; Nesi G; Ferrero S; Furlan D; Poggioli G; Rizzello F; Macciomei MC; Santini D; Volta U; De Giorgio R; Caio G; Calabrò A; Ciacci C; D'Armiento M; Rizzo A; Solina G; Martino M; Tonelli F; Villanacci V; Cannizzaro R; Canzonieri V; Florena AM; Biancone L; Monteleone G; Caronna R; Ciardi A; Elli L; Caprioli F; Vecchi M; D'Incà R; Zingone F; D'Odorico A; Lenti MV; Oreggia B; Reggiani Bonetti L; Astegiano M; Biletta E; Cantoro L; Giannone AG; Orlandi A; Papi C; Perfetti V; Quaquarini E; Sandri G; Silano M; Usai P; Barresi V; Ciccocioppo R; Luinetti O; Pedrazzoli P; Pietrabissa A; Viglio A; Paulli M; Corazza GR; Solcia E; Vanoli A; Di Sabatino A Mod Pathol; 2020 Jul; 33(7):1398-1409. PubMed ID: 32066859 [TBL] [Abstract][Full Text] [Related]
9. Clinicopathological and molecular stability and methylation analyses of gastric papillary adenocarcinoma. Uesugi N; Sugai T; Sugimoto R; Eizuka M; Fujita Y; Sato A; Osakabe M; Ishida K; Koeda K; Sasaki A; Matsumoto T Pathology; 2017 Oct; 49(6):596-603. PubMed ID: 28830689 [TBL] [Abstract][Full Text] [Related]
11. New insights into the inflamed tumor immune microenvironment of gastric cancer with lymphoid stroma: from morphology and digital analysis to gene expression. Gullo I; Oliveira P; Athelogou M; Gonçalves G; Pinto ML; Carvalho J; Valente A; Pinheiro H; Andrade S; Almeida GM; Huss R; Das K; Tan P; Machado JC; Oliveira C; Carneiro F Gastric Cancer; 2019 Jan; 22(1):77-90. PubMed ID: 29779068 [TBL] [Abstract][Full Text] [Related]
12. PD-L1 expression in colorectal cancer is associated with microsatellite instability, BRAF mutation, medullary morphology and cytotoxic tumor-infiltrating lymphocytes. Rosenbaum MW; Bledsoe JR; Morales-Oyarvide V; Huynh TG; Mino-Kenudson M Mod Pathol; 2016 Sep; 29(9):1104-12. PubMed ID: 27198569 [TBL] [Abstract][Full Text] [Related]
13. p53 immunostaining cannot be used to predict TP53 mutations in gastric cancer: results from a large Central European cohort. Schoop I; Maleki SS; Behrens HM; Krüger S; Haag J; Röcken C Hum Pathol; 2020 Nov; 105():53-66. PubMed ID: 32971129 [TBL] [Abstract][Full Text] [Related]
14. Programmed Death-Ligand 1 Expression, Microsatellite Instability, Epstein-Barr Virus, and Human Papillomavirus in Nasopharyngeal Carcinomas of Patients from the Philippines. Chang AMV; Chiosea SI; Altman A; Pagdanganan HA; Ma C Head Neck Pathol; 2017 Jun; 11(2):203-211. PubMed ID: 27807760 [TBL] [Abstract][Full Text] [Related]
15. Programmed Death-Ligand 1 Expression Is Common in Gastric Cancer Associated With Epstein-Barr Virus or Microsatellite Instability. Ma C; Patel K; Singhi AD; Ren B; Zhu B; Shaikh F; Sun W Am J Surg Pathol; 2016 Nov; 40(11):1496-1506. PubMed ID: 27465786 [TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic Features and Prognostic Significance of Immunohistochemistry and In Situ Hybridization Based Molecular Classification in Gastric Carcinoma. Issin G; Sayar İ; Demir F; Bakkaloğlu İG; Gamsizkan M; Yildiz Z; Yilmaz I; Özmen SA; Çağatay DV; Zemheri IE; Demiriz M; Günal A J Environ Pathol Toxicol Oncol; 2023; 42(4):1-14. PubMed ID: 37522564 [TBL] [Abstract][Full Text] [Related]
17. The Transcriptomic Landscape of Gastric Cancer: Insights into Epstein-Barr Virus Infected and Microsatellite Unstable Tumors. Gullo I; Carvalho J; Martins D; Lemos D; Monteiro AR; Ferreira M; Das K; Tan P; Oliveira C; Carneiro F; Oliveira P Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30018250 [TBL] [Abstract][Full Text] [Related]
18. Prognostic and immune infiltration significance of ARID1A in TCGA molecular subtypes of gastric adenocarcinoma. Zhang Z; Li Q; Sun S; Ye J; Li Z; Cui Z; Liu Q; Zhang Y; Xiong S; Zhang S Cancer Med; 2023 Aug; 12(16):16716-16733. PubMed ID: 37366273 [TBL] [Abstract][Full Text] [Related]
19. An Integrative Morphomolecular Classification System of Gastric Carcinoma With Distinct Clinical Outcomes. Tsai JH; Jeng YM; Chen KH; Lee CH; Yuan CT; Liau JY Am J Surg Pathol; 2020 Aug; 44(8):1017-1030. PubMed ID: 32568823 [TBL] [Abstract][Full Text] [Related]
20. Solid-type poorly differentiated adenocarcinoma of the stomach: clinicopathological and molecular characteristics and histogenesis. Arai T; Matsuda Y; Aida J; Takubo K; Ishiwata T Gastric Cancer; 2019 Mar; 22(2):314-322. PubMed ID: 30088163 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]